T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.01B |
| 2 |
Broadcom
AVGO
|
+$1.49B |
| 3 |
GE Vernova
GEV
|
+$1.19B |
| 4 |
International Paper
IP
|
+$1.05B |
| 5 |
SCHW
Charles Schwab
SCHW
|
+$952M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.31B |
| 2 |
Constellation Energy
CEG
|
+$1.94B |
| 3 |
Qualcomm
QCOM
|
+$1.74B |
| 4 |
NVIDIA
NVDA
|
+$1.71B |
| 5 |
Salesforce
CRM
|
+$1.5B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.98% |
| 2 | Healthcare | 14.89% |
| 3 | Financials | 10.35% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Communication Services | 9.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
Boston Beer
SAM
$1.89B
| $2.68M | ﹤0.01% |
8,780
-434
| -5% | -$124K |
|
1427
BGC Group
BGC
$5.12B
| $2.67M | ﹤0.01% |
321,886
+14,979
| +5% | +$123K |
|
1428
Madison Square Garden
MSGS
$9.97B
| $2.66M | ﹤0.01% |
14,120
+211
| +2% | +$39.1K |
|
1429
Pacific Biosciences
PACB
$357M
| $2.66M | ﹤0.01% |
1,939,234
-16,148
| -0.8% | -$32.6K |
|
|
ESGR
1430
DELISTED
Enstar Group
ESGR
| $2.64M | ﹤0.01% |
8,625
+617
| +8% | +$185K |
|
1431
Sonoco
SON
$5.74B
| $2.63M | ﹤0.01% |
51,938
+1,625
| +3% | +$93.9K |
|
1432
Bank OZK
OZK
$5.69B
| $2.63M | ﹤0.01% |
64,206
+1,762
| +3% | +$76.7K |
|
1433
MDU Resources
MDU
$4.27B
| $2.63M | ﹤0.01% |
189,002
+14,834
| +9% | +$205K |
|
1434
UBS Group
UBS
$176B
| $2.63M | ﹤0.01% |
+88,900
| New | +$2.64M |
|
1435
Lincoln National
LNC
$8.44B
| $2.62M | ﹤0.01% |
84,267
+6,123
| +8% | +$185K |
|
1436
UMB Financial
UMBF
$11.4B
| $2.62M | ﹤0.01% |
31,357
+1,602
| +5% | +$131K |
|
1437
Roivant Sciences
ROIV
$26.2B
| $2.61M | ﹤0.01% |
247,224
-353,645
| -59% | -$3.88M |
|
1438
Dole
DOLE
$1.23B
| $2.61M | ﹤0.01% |
213,259
+73,483
| +53% | +$893K |
|
1439
Helmerich & Payne
HP
$4.29B
| $2.6M | ﹤0.01% |
72,056
-25,243
| -26% | -$971K |
|
1440
First Financial Bankshares
FFIN
$5.01B
| $2.6M | ﹤0.01% |
87,946
+3,850
| +5% | +$115K |
|
1441
Zurn Elkay Water Solutions
ZWS
$8.46B
| $2.59M | ﹤0.01% |
87,928
+3,833
| +5% | +$121K |
|
1442
Piper Sandler
PIPR
$5.34B
| $2.57M | ﹤0.01% |
44,672
+1,668
| +4% | +$85.5K |
|
|
JBTM
1443
JBT Marel
JBTM
$6.15B
| $2.56M | ﹤0.01% |
26,979
-172,525
| -86% | -$16.3M |
|
1444
Boot Barn
BOOT
$4.87B
| $2.55M | ﹤0.01% |
19,801
+1,079
| +6% | +$121K |
|
1445
Avient
AVNT
$4.16B
| $2.55M | ﹤0.01% |
58,323
+3,667
| +7% | +$161K |
|
1446
Acumen Pharmaceuticals
ABOS
$182M
| $2.53M | ﹤0.01% |
1,046,364
-51,912
| -5% | -$165K |
|
1447
American States Water
AWR
$3.49B
| $2.52M | ﹤0.01% |
34,769
+1,261
| +4% | +$91K |
|
1448
Cedar Fair
FUN
$1.68B
| $2.52M | ﹤0.01% |
46,407
| – | – |
|
1449
Polaris
PII
$3.9B
| $2.51M | ﹤0.01% |
32,048
+596
| +2% | +$50.5K |
|
1450
Black Hills Corp
BKH
$5.58B
| $2.5M | ﹤0.01% |
46,009
+1,232
| +3% | +$67.1K |
|
Similar funds
T. Rowe Price Associates's Q2 2024 Portfolio in Review
As of Q2 2024, T. Rowe Price Associates held 3,089 positions worth $836B, up 2.4% from $816B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
T. Rowe Price Associates's Q2 2024 filing shows 135 new, 1,850 increased, 836 reduced and 113 closed positions. Its largest new stake was Tempus AI: 5,227,120 shares worth $183M. The largest sale was Microsoft, an estimated $2.31B.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2024 buy was Tempus AI: 5,227,120 shares worth $183M.
- T. Rowe Price Associates added most to Apple in Q2 2024, an estimated $4.01B increase.
- T. Rowe Price Associates's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.31B.
- T. Rowe Price Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $570M.
- T. Rowe Price Associates's ten largest holdings make up 36% of its $836B portfolio in Q2 2024.
- T. Rowe Price Associates opened 135 new positions and closed 113 in Q2 2024.
- T. Rowe Price Associates's portfolio value rose 2.4% quarter-over-quarter to $836B.
Based on T. Rowe Price Associates's 13F filing for Q2 2024, filed 14 Aug 2024.